Literature DB >> 23080174

Effect of oxygen on phosphodiesterases (PDE) 3 and 4 isoforms and PKA activity in the superior cervical ganglia.

Ana Rita Nunes1, Vedangi Sample, Yang K Xiang, Emília C Monteiro, Estelle Gauda, Jin Zhang.   

Abstract

UNLABELLED: The cAMP-protein kinase A (PKA) signaling pathway is involved in regulating the release of transmitters from neurons and other cells. Multiple phosphodiesterase (PDE) isoforms regulate this pathway, however, the pattern of isoform expression and stimulus response across tissues has not been fully characterized.Using fluorescent resonance energy transfer (FRET)-based imaging in primary superior cervical ganglia (SCG) neurons and real-time qPCR, we explored the role of PDE3 and PDE4 isoforms and oxygen tension in the activation of PKA and changes in gene expression. These primary neurons were infected with an adenovirus containing A-Kinase activity reporter (AKAR3) and assayed for responses to PDE inhibitors: rolipram (ROL, 1 μM), milrinone (MIL, 10 μM) and IBMX (100 μM), and adenylyl cyclase activator forskolin (FSK, 50 μM). Different PDE activity patterns were observed in different cells: high PDE4 activity (n = 3), high PDE3 activity (n = 3) and presence of activity of other PDEs (n = 3). Addition of PKA inhibitor H89 (10 μM) completely reversed the response. We further studied the effect of oxygen in the PKA activity induced by PDE inhibition. Both normoxia (20%O(2)/5%CO(2)) and hypoxia (0%O(2)/5%CO(2)) induced a similar increase in the FRET emission ratio (14.5 ± 0.8 and 14.7 ± 0.8, respectively).PDE3a, PDE4b and PDE4d isoforms mRNAs were highly expressed in the whole SCG with no modulation by hypoxia.
CONCLUSION: Using a FRET-based PKA activity sensor, we show that primary SCG neurons can be used as a model system to dissect the contribution of different PDE isoforms in regulating cAMP/PKA signaling. The differential patterns of PDE regulation potentially represent subpopulations of ganglion cells with different physiological functions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23080174      PMCID: PMC3715042          DOI: 10.1007/978-94-007-4584-1_39

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  7 in total

Review 1.  Network of the sympathetic nervous system: focus on the input and output of the cervical sympathetic ganglion.

Authors:  Ken Asamoto
Journal:  Anat Sci Int       Date:  2005-09       Impact factor: 1.741

2.  Physiological classification of sympathetic neurons in the rat superior cervical ganglion.

Authors:  Chen Li; John P Horn
Journal:  J Neurophysiol       Date:  2005-09-21       Impact factor: 2.714

Review 3.  Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use.

Authors:  Andrew T Bender; Joseph A Beavo
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

4.  Effects of different types of stimulation on cyclic AMP content in the rabbit carotid body: functional significance.

Authors:  M T Pérez-García; L Almaraz; C González
Journal:  J Neurochem       Date:  1990-10       Impact factor: 5.372

5.  Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues.

Authors:  Viktor Lakics; Eric H Karran; Frank G Boess
Journal:  Neuropharmacology       Date:  2010-05-21       Impact factor: 5.250

6.  Acute hypoxia modifies cAMP levels induced by inhibitors of phosphodiesterase-4 in rat carotid bodies, carotid arteries and superior cervical ganglia.

Authors:  Ana R Nunes; Joana R Batuca; Emília C Monteiro
Journal:  Br J Pharmacol       Date:  2010-01-15       Impact factor: 8.739

7.  Activities of 3':5' cyclic nucleotide phosphodiesterases in the superior cervical ganglion of rat: characterization, compartmentalization and observations in young and old animals.

Authors:  M Giorgi; R Squitti; P Bonsi; P Paggi; G Toschi
Journal:  Neurochem Int       Date:  1994-11       Impact factor: 3.921

  7 in total
  7 in total

1.  Dysregulation of Neuronal Ca2+ Channel Linked to Heightened Sympathetic Phenotype in Prohypertensive States.

Authors:  Hege E Larsen; Emma N Bardsley; Konstantinos Lefkimmiatis; David J Paterson
Journal:  J Neurosci       Date:  2016-08-17       Impact factor: 6.167

Review 2.  Genetically encoded fluorescent biosensors for live-cell visualization of protein phosphorylation.

Authors:  Laurel Oldach; Jin Zhang
Journal:  Chem Biol       Date:  2014-01-30

3.  Real-time relationship between PKA biochemical signal network dynamics and increased action potential firing rate in heart pacemaker cells: Kinetics of PKA activation in heart pacemaker cells.

Authors:  Yael Yaniv; Ambhighainath Ganesan; Dongmei Yang; Bruce D Ziman; Alexey E Lyashkov; Andre Levchenko; Jin Zhang; Edward G Lakatta
Journal:  J Mol Cell Cardiol       Date:  2015-08-01       Impact factor: 5.000

4.  Inhibition of endogenous phosphodiesterase 7 promotes oligodendrocyte precursor differentiation and survival.

Authors:  E M Medina-Rodríguez; F J Arenzana; J Pastor; M Redondo; V Palomo; R García de Sola; C Gil; A Martínez; A Bribián; F de Castro
Journal:  Cell Mol Life Sci       Date:  2013-05-10       Impact factor: 9.261

5.  Effect of Mitochondrial Antioxidant (Mito-TEMPO) on Burn-Induced Cardiac Dysfunction.

Authors:  Jake J Wen; Taylor P Williams; Claire B Cummins; Kayla M Colvill; Geetha L Radhakrishnan; Ravi S Radhakrishnan
Journal:  J Am Coll Surg       Date:  2021-01-07       Impact factor: 6.113

6.  Loss of Cervical Sympathetic Chain Input to the Superior Cervical Ganglia Affects the Ventilatory Responses to Hypoxic Challenge in Freely-Moving C57BL6 Mice.

Authors:  Paulina M Getsy; Gregory A Coffee; Yee-Hsee Hsieh; Stephen J Lewis
Journal:  Front Physiol       Date:  2021-04-22       Impact factor: 4.566

7.  The analgesic effect of rolipram is associated with the inhibition of the activation of the spinal astrocytic JNK/CCL2 pathway in bone cancer pain.

Authors:  Chi-Hua Guo; Lu Bai; Huang-Hui Wu; Jing Yang; Guo-Hong Cai; Xin Wang; Sheng-Xi Wu; Wei Ma
Journal:  Int J Mol Med       Date:  2016-09-30       Impact factor: 4.101

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.